Wealth Enhancement Advisory Services
NGEN

Wealth Enhancement Advisory Services’s NervGen Pharma NGEN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio NGEN Stock Details NGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.9K Buy
+16,462
New +$51.1K ﹤0.01% 3988

Other funds holding NGEN

TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
RWM
Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return
APW
Aventura Private Wealth Aventura, Florida $326M AUM 34.36% 1-Year Est. Return

Wealth Enhancement Advisory Services's NGEN Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in NervGen Pharma (NGEN) in Q2 2026: 16,462 shares worth $30.9K. The stake represents ﹤0.01% of the portfolio and ranks #3988 among its holdings.

5 funds tracked by Wall St. Rank hold NGEN as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,462 shares of NervGen Pharma worth $30.9K as of Q2 2026.
  • NervGen Pharma was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • NervGen Pharma made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3988 holding.
  • 5 funds tracked by Wall St. Rank held NervGen Pharma as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.